WHO ICTRP trial
TNFR2 Agonism and the Ex Vivo Expansion of Regulatory T Cells of Patients with…
NL-OMON50055 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON50055 |
|---|---|
| Public title | TNFR2 Agonism and the Ex Vivo Expansion of Regulatory T Cells of Patients with Autoimmune or Inflammatory Disease |
| Scientific title | TNFR2 Agonism and the Ex Vivo Expansion of Regulatory T Cells of Patients with Autoimmune or Inflammatory Disease - TNFR2 Agonism and Ex Vivo Expansion of Regulatory T Cells |
| Primary sponsor | Universiteit Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | 'AAV'; 'Crohn's disease' 'CD' 'MS'; 'Systemic lupus erythematosus' 'Multiple sclerosis' 'SLE'; 'ANCA-associated vasculitides';10017969;10003816;10012303;'AAV'; 'Crohn's disease';'CD';'MS'; 'Systemic lupus erythematosus';'Multiple… |
| Interventions | ;Autoimmune disease;Ex vivo expansion;Regulatory T-lymphocyte;TNFR2 agonism |
| Registration date | Feb 7, 2019 |
| Target size | 60 |
| Secondary IDs | NL59692.068.16 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: